Avobis Bio Unveils Positive STOMP2 Trial Results At ACG Meeting
29 Oct 2025 //
PR NEWSWIRE
FDA Designates Avobis Bio`s AVB-114 For Crohn`s Fistulas
03 Oct 2025 //
PR NEWSWIRE
Avobis Completes Primary Analysis of AVB-114 in Crohn`s Fistulas
08 Aug 2025 //
PR NEWSWIRE
Avobis Bio Gets FDA Fast Track for AVB-114 Cell Therapy
27 Feb 2025 //
PR NEWSWIRE

Market Place
Sourcing Support